Catherine Teh1San-Jun Cai2Chuan-Gang Fu3Jin Gu4Yu-Long He5Bao-QingLan Ping Jia7Chun Song8Jian-Min Xu9Rui-Hua Xu10Su-Zhan Zhang11Ai-Ping Zhou12Rico King-yin LIU13Brigette Ma14Shailesh V. Shrikhande15S.P. Somasekhar16Sun Young Kim17Tae Won Kim18Young Suk Park19Christina Ng Van Tze20Tan Iain21Chien-Chih Chen22Jinn-Shiun Chen23William Tzu-Liang Chen24Jenq-Chang Lee25Jen-Kou Lin26Hwei-Ming Wang27Jaw-Yuan Wang28Ekaphop Sirachainan29
1. Makati Medical Center,Philippines2. Fudan University Shanghai Cancer Center3. Changhai Hospital, Second Military Medical University,Shanghai4. Beijing Cancer Hospital5. The 1st Affiliated Hospital, Sun Yat-Sen University6. The General Hospital of the People’s Liberation Army7. The Sixth Affiliated Hospital of Sun Yat-Sen University8. Liaoning Cancer Hospital and Institute9. Zhongshan Hospital, Fudan University,Shanghai10. Sun Yat-Sen University Cancer Center,Guangzhou11. Second Affiliated Hospital,Zhejiang Province12. Chinese Academy of Medical Sciences & Peking Union Medical College13. Queen Mary Hospital14. Prince of Wales Hospital15. Tata Memorial Center,India16. Manipal Hospital,India17. National Cancer Center,South Korea18. Asan Medical Center,South Korea19. Samsung Medical Center,South Korea20. Sunway Medical Center,Malaysia21. National Cancer Center,Singapore22. Koo Foundation Sun Yat-Sen Cancer Center23. Chang Gung Memorial Hospital,Linkou24. China Medical University Hospital25. National Cheng Kung University Hospital26. Taipei Veteran General Hospital27. Taichung Veterans General Hospital28. Kaohsiung Medical University and Hospital29. Ramthibodi Hospital,Thailand
摘要：Colorectal cancer （CRC） is currently the fourth most common cause of cancer death worldwide. Approximately 50% of patients develop distant metastases in the liver, which is the most common site; approximately 25% of patients exhibit synchronous metastases at the time of diagnosis. Although CRC-related deaths have decreased in the western world over the past few years, a twofold to fourfold increase in the incidence of CRC has been observed in Asian countries of China, Japan, Korea, and Singapore over the last two decades. With various ethnic, epidemiological, and genetic differences, strategies should be developed to manage CRC in Asia. Thus, the Network of Colorectal Cancer Multi-Disciplinary Teams in Asia Pacific Region （NECTAR） was established in 2011. The NECTAR initiative aims to build an excellent Asian network of centers that share common frameworks, protocols, and treatment goals based on evidence and best practice approach in the management of metastatic colorectal cancer （mCRC）. The NECTAR group consists of members from 29 centers from nine Asian countries, which form the NECTAR Council, who meets periodically to discuss and formulate activities and initiatives; such activities aim to attain the objectives established by a group of experts. As the first step to create a common framework of oncosurgical approach and best-practice sharing of treatment guidelines, a database of Asian patients’ registry and a regional preceptorship program were considered essential by the NECTAR council. A few short-term goals of the NECTAR Council include the following: （1） develop consensus statements on the standard practice to treat liver-only metastasis in mCRC and （2） publish a questionnaire or survey report on attitudes and satisfaction level with multidisciplinary team （MDT） adoption, on patient, physician and hospital administration basis. The long-term goals include the following: （1） promote the practice of MDT in the management of liver-only metastasis in Asia and （2） establish the opinion-leadership role of the NECTAR Council internationally.
The 22nd Asia Pacific Cancer Conference